Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
about
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.Drug Repurposing for the Treatment of Acute Myeloid Leukemia.Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.Precision therapy for acute myeloid leukemia.Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study.
P2860
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Therapeutic value of clofarabi ...... ults with newly diagnosed AML.
@en
Therapeutic value of clofarabine in younger and middle-aged
@nl
type
label
Therapeutic value of clofarabi ...... ults with newly diagnosed AML.
@en
Therapeutic value of clofarabine in younger and middle-aged
@nl
prefLabel
Therapeutic value of clofarabi ...... ults with newly diagnosed AML.
@en
Therapeutic value of clofarabine in younger and middle-aged
@nl
P2093
P50
P1433
P1476
Therapeutic value of clofarabi ...... ults with newly diagnosed AML.
@en
P2093
Arjan A van de Loosdrecht
Bart J Biemond
Beata Hodossy
Carlos Graux
Daniëlle van Lammeren-Venema
Dimitri A Breems
Dutch-Belgian Hemato-Oncology ...... linical Cancer Research (SAKK)
Edo Vellenga
Georgine E de Greef
Gert J Ossenkoppele
P304
P356
10.1182/BLOOD-2016-10-740613
P407
P577
2017-01-03T00:00:00Z